OCTAPHARMA FRANCE

Group: Octapharma GmbH(inferred)

Reg. 45132730800024

Contracts this supplier holds that are running out

• 31 May 2029statedFACTEUR VIII HUMAIN PLASMATIQUEHospices Civils de LyonOCTAPHARMA FRANCE€11,052,377
• 31 May 2029statedFACTEUR IX HUMAIN PLASMATIQUE sécurisation virale SD et nanofiltration à 20 nmHospices Civils de LyonOCTAPHARMA FRANCE€598,930
• 31 May 2029statedFACTEUR VIII RECOMBINANT - SIMOCTOCOG ALFAHospices Civils de LyonOCTAPHARMA FRANCE€6,787,519
• 31 May 2029statedPLASMA THERAPEUTIQUEHospices Civils de LyonOCTAPHARMA FRANCE€4,103,829
• 31 May 2029statedCOMPLEXE PROTHROMBINIQUE HUMAINHospices Civils de LyonOCTAPHARMA FRANCE€15,056,588
• 31 May 2029statedFIBRINOGENE HUMAINHospices Civils de LyonLFB BIOMEDICAMENTS, OCTAPHARMA FRANCE€69,652,461
• 31 May 2029statedANTITHROMBINE HUMAINEHospices Civils de LyonOCTAPHARMA FRANCE€9,466,038
• 31 May 2029statedASSOCIATION FVIII HUMAIN ET F WILLEBRAND HUMAIN A DOSES EQUIVALENTESHospices Civils de LyonOCTAPHARMA FRANCE€2,840,509
• 31 May 2029statedIG POLYVALENTE HUMAINE SOUS CUTANEE FORME INJECTABLE 165 MG / MLHospices Civils de LyonOCTAPHARMA FRANCE€59,774,416
• 31 May 2029statedIG POLYVALENTE HUMAINE IV 50 MG / ML (5%) PAE - stabilisé au MALTOSEHospices Civils de LyonOCTAPHARMA FRANCE€24,142,500
• 31 May 2029statedIG POLYVALENTE HUMAINE IV 100 MG / ML (10%) PAE - stabilisé au MALTOSEHospices Civils de LyonOCTAPHARMA FRANCE€6,993,887

All expiring contracts →

Awards